Announced Sat, 26 Sept, 2026 · 15:12 IST

Board meeting on Nov 14 to consider Q2 FY27 results

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹232.00

prior close

₹238.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+2.3% vs market

Pharmaceuticals peers, median of 172sector-1.5%+2.2% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

-0.3

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7-1.6+2.3-1.5+2.2

Next day

+3.4-0.6+4.0-1.0+4.4

+0.3-0.8+1.1-1.9+2.2

+0.0-2.1+2.1-2.5+2.5

+3.7-2.1+5.8-3.4+7.1

+3.0-0.8+3.8-2.4+5.4

+1.7-3.8+5.5-4.3+5.9

15d

+18.0-6.9+24.9-7.9+25.9

+14.7pendingpending-6.6+21.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Samrat Pharmachem Limited has informed BSE that the Board of Directors will meet on November 14, 2026 at 2:00 PM at the corporate office in Andheri West, Mumbai. The meeting will consider and approve the Un-Audited Financial Results under Ind-AS for the quarter ended September 30, 2026.

Likely market impact

Routine quarterly results announcement. Watch for actual numbers on Nov 14 for any earnings surprises or guidance updates.